Thursday, January 21, 2021
Home Latest News Federal News CMS proposes rule to require manufacturers to disclose drug prices

CMS proposes rule to require manufacturers to disclose drug prices

The Centers for Medicare & Medicaid Services (CMS) has proposed a rule (CMS-4187) that will require prescription drug manufacturers to disclose in television ads the wholesale acquisition cost for Medicare or Medicaid prescription drugs.

The proposed rule is the latest in President Trump’s efforts to lower prescription drug prices and increase price transparency. Under the proposed rule, the price required to be posted would be for a typical course of treatment for an acute medication like an antibiotic, or a 30-day supply of medication for a chronic condition that is taken every month. The posting would take the form of a legible statement at the end of the ad. Prescription drugs with a list price of less than $35 per month would be exempt.

Read the policy brief on CMS-4187 and the proposed rule. Comments will be accepted until Dec. 17 and can be submitted here.

Stay Connected

Unified Voice Newsletter

Events This Month

january

21jan12:00 pm1:00 pmWebinar: PDGM Tips and Utilization Strategies12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

21jan12:00 pm1:00 pmCOVID-19 Visitation Practices for Hospitals and Health Systems12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

21jan12:30 pm1:30 pm2-Part Webinar Series: Optimizing Therapy Services Considering COVID Challenges12:30 pm - 1:30 pm CST Event Type :Education Events,Webinar

22jan11:00 am1:00 pmHome Care Industry Legal Update Webinar11:00 am - 1:00 pm CST Event Type :Education Events,Webinar

X

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact